Association of low-dose aspirin and survival of women with endometrial cancer

Obstetrics and Gynecology

Volumn 128, Issue 1, 2016, Pages 127-137

  Matsuo, Koji ^a   Cahoon, Sigita S ^a   Yoshihara, Kosuke ^a   Shida, Masako ^a   Kakuda, Mamoru ^a   Adachi, Sosuke ^a   Moeini, Aida ^a   Machida, Hiroko ^a   Garcia Sayre, Jocelyn ^a   Ueda, Yutaka ^a   Enomoto, Takayuki ^a   Mikami, Mikio ^a   Roman, Lynda D ^a   Sood, Anil K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CARBOPLATIN; DOCETAXEL; EPIRUBICIN; HYPOCHOLESTEROLEMIC AGENT; PACLITAXEL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DIABETES MELLITUS; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYSTERECTOMY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; ADENOCARCINOMA; AGED; CANCER STAGING; CLINICAL TRIAL; COMORBIDITY; DOSE RESPONSE; ENDOMETRIAL NEOPLASMS; JAPAN; MULTICENTER STUDY; OBESITY; PATHOLOGY; STATISTICS; SURVIVAL ANALYSIS; UNITED STATES;

ADENOCARCINOMA; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COMORBIDITY; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; MIDDLE AGED; NEOPLASM STAGING; OBESITY; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84973343809     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001491     Document Type: Article

References (28)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
2. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) 2013;37:889-91.
3. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-31.
4. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancerrelated inflammation and treatment effectiveness. Lancet Oncol 2014;15:e493-503.
5. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005;14:2840-7.
6. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013;1831:1533-41.
7. Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM, et al. Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-Analysis. Int J Cancer 2013;132:1146-55.
8. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57:3239-46.
9. Mantovani A, Romero P, Palucka AK, Marincola FM. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 2008;371:771-83.
10. Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S, et al. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 2009;18:1448-56.
11. Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS. Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol 2009;170:1512-7.
12. Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res 2008;68:2507-13.
13. Moysich KB, Baker JA, Rodabaugh KJ, Villella JA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2923-8.
14. Nevadunsky NS, Van Arsdale A, Strickler HD, Spoozak LA, Moadel A, Kaur G, et al. Association between statin use and endometrial cancer survival. Obstet Gynecol 2015;126:144-50.
15. Pierce SR, Doll KM, Davidson B, Lee C, Ko EM, Snavely AC, et al. Endometrial cancer outcomes in diabetic women treated with metformin, statins, and aspirin. Gynecol Oncol 2014; 133:43.
16. STROBE guideline Available at: http://www.strobe-statement. org/. Retrieved April 1, 2015.
17. Matsuo K, Moeini A, Machida H, Scannell CA, Casabar JK, Kakuda M, et al. Tumor characteristics and survival outcome of endometrial cancer arising in adenomyosis: an exploratory analysis. Ann Surg Oncol 2016;23:959-67.
18. Rose PG. Endometrial carcinoma. N Engl J Med 1996;335: 640-9.
19. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105: 103-4.
20. Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, et al. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 2008;108: 221-9.
21. Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, et al. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-A clinical and pathological evaluation. Gynecol Oncol 2012;124:15-20.
22. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, et al. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol 2015;125:424-33.
23. Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, et al. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. J Surg Oncol 2015;112:669-76.
24. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007;356:2131-42.
25. Zhao Y, Agarwal VR, Mendelson CR, Simpson ER. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 1996;137:5739-42.
26. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, et al. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 2004;291:2433-40.
27. Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet 2012;379:1352-60.
28. Meyer LA, Bohlke K, Powell MA, Fader AN, Franklin GE, Lee LJ, et al. Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol 2015; 33:2908-13.